Malaria: immune evasion by parasites

被引:62
作者
Hisaeda, H
Yasutomo, K
Himeno, K
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Parasitol, Higashi Ku, Fukuoka 8128582, Japan
[2] Univ Tokushima, Inst Hlth Biosci, Dept Immunol & Parasitol, Grad Sch, Tokushima 7708503, Japan
关键词
malaria; immune evasion; regulatory T cells;
D O I
10.1016/j.biocel.2004.10.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Malaria is one of the most life-threatening infectious diseases worldwide. Specific immunity to natural infection is acquired slowly despite a high degree of repeated exposure and rarely continues for a long time even in endemic areas. Malaria parasites have evolved to acquire diverse immune evasion mechanisms that evoke poor immune responses and allow infection of individuals previously exposed. The shrewd schema of malaria parasites also hampers the development of effective vaccines. Furthermore, some of those mechanisms are essential for malaria pathogenesis. In this article, an outline of protective immunity to malaria is given, then strategies used by malaria parasites to evade host immunity, including antigen diversity/polymorphism, antigen variation and total immune suppression, are reviewed. Finally, trials to control malaria based on accumulating insights into the host-parasite relationship are discussed. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:700 / 706
页数:7
相关论文
共 21 条
[1]   Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line [J].
Baruch, DI ;
Gamain, B ;
Barnwell, JW ;
Sullivan, JS ;
Stowers, A ;
Galland, GG ;
Miller, LH ;
Collins, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3860-3865
[2]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[3]  
BURNS JM, 1989, J IMMUNOL, V142, P2835
[4]   Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta [J].
Fried, M ;
Duffy, PE .
SCIENCE, 1996, 272 (5267) :1502-1504
[5]   Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections [J].
Giha, HA ;
Staalsoe, T ;
Dodoo, D ;
Roper, C ;
Satti, GMH ;
Arnot, DE ;
Hviid, L ;
Theander, TG .
IMMUNOLOGY LETTERS, 2000, 71 (02) :117-126
[6]   Pathways and strategies for developing a malaria blood-stage vaccine [J].
Good, MF ;
Kaslow, DC ;
Miller, LH .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :57-87
[7]   Escape of malaria parasites from host immunity requires CD4+CD25+ regulatory T cells [J].
Hisaeda, H ;
Maekawa, Y ;
Iwakawa, D ;
Okada, H ;
Himeno, K ;
Kishihara, K ;
Tsukumo, S ;
Yasutomo, K .
NATURE MEDICINE, 2004, 10 (01) :29-30
[8]   Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic, and immunosuppressive substances in humans [J].
Kubata, BK ;
Eguchi, N ;
Urade, Y ;
Yamashita, K ;
Mitamura, T ;
Tai, K ;
Hayaishi, O ;
Horii, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (06) :1197-1202
[9]   PLASMODIUM-FALCIPARUM MALARIA - ULTRASTRUCTURE OF PARASITIZED ERYTHROCYTES IN CARDIAC VESSELS [J].
LUSE, SA ;
MILLER, LH .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1971, 20 (05) :655-&
[10]   The pathogenic basis of malaria [J].
Miller, LH ;
Baruch, DI ;
Marsh, K ;
Doumbo, OK .
NATURE, 2002, 415 (6872) :673-679